Markets:

Overview

News

Currencies

International

Treasuries

Stoke Therapeutics, Inc. - Common Stock (NQ:STOK)

26.93 +0.32 (+1.20%)

Delayed Quote Updated: 9:58 AM EDT, Oct 21, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Stoke Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

August 16, 2024

From Stoke Therapeutics, Inc.

Via Business Wire

Stoke Therapeutics Reports Second Quarter Financial Results and Provides Business Updates

August 07, 2024

From Stoke Therapeutics, Inc.

Via Business Wire

Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

July 16, 2024

From Stoke Therapeutics, Inc.

Via Business Wire

A Closer Look at 5 Analyst Recommendations For Stoke Therapeutics ↗

June 28, 2024

Via Benzinga

Analyst Expectations For Stoke Therapeutics's Future ↗

May 06, 2024

Via Benzinga

Assessing Stoke Therapeutics: Insights From 6 Financial Analysts ↗

April 04, 2024

Via Benzinga

Enerpac Tool Group, Singular Genomics Systems And 3 Stocks To Watch On Monday ↗

June 24, 2024

Via Benzinga

Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

June 18, 2024

From Stoke Therapeutics, Inc.

Via Business Wire

Stoke Therapeutics to Present at Upcoming Investor Conferences in June

June 03, 2024

From Stoke Therapeutics, Inc.

Via Business Wire

Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

May 17, 2024

From Stoke Therapeutics, Inc.

Via Business Wire

STOK Stock Earnings: Stoke Therapeutics Beats EPS, Beats Revenue for Q1 2024 ↗

May 06, 2024

STOK stock results show that Stoke Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

Stoke Therapeutics Reports First Quarter Financial Results and Provides Business Updates

May 06, 2024

From Stoke Therapeutics, Inc.

Via Business Wire

Stoke Therapeutics Appoints Thomas Leggett as Chief Financial Officer

April 29, 2024

From Stoke Therapeutics, Inc.

Via Business Wire

Stoke Therapeutics Appoints Jason Hoitt as Chief Commercial Officer

April 17, 2024

From Stoke Therapeutics, Inc.

Via Business Wire

12 Health Care Stocks Moving In Friday's After-Market Session ↗

April 05, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

April 04, 2024

Via Benzinga

Stoke Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference

April 04, 2024

From Stoke Therapeutics, Inc.

Via Business Wire

Stoke Therapeutics Announces Pricing of Upsized $125 Million Public Offering

March 27, 2024

From Stoke Therapeutics, Inc.

Via Business Wire

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

March 27, 2024

Via Benzinga

What's Going On With Stoke Therapeutics Stock Tuesday? ↗

March 26, 2024

After the market close on Tuesday, Stoke Therapeutics announced a proposed underwritten public offering of up to $75 million of its common stock. The company also intends to grant the underwriters a...

Via Benzinga

Stoke Therapeutics Announces Proposed Public Offering

March 26, 2024

From Stoke Therapeutics, Inc.

Via Business Wire

Crude Oil Moves Lower; TD SYNNEX Earnings Top Estimates ↗

March 26, 2024

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining over 80 points on Tuesday. The Dow traded up 0.21% to 39,397.20 while the NASDAQ rose 0.23% to 16,421.62. The S&P 500...

Via Benzinga

Topics Stocks

Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

March 26, 2024

Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected fourth-quarter loss. Westport Fuel Systems posted a quarter loss of 81...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

March 26, 2024

Via Benzinga

Dow Gains 100 Points; McCormick Posts Upbeat Results ↗

March 26, 2024

U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 100 points on Tuesday. The Dow traded up 0.25% to 39,413.30 while the NASDAQ rose 0.27% to 16,448.55. The S&P 500...

Via Benzinga

Topics Stocks

Stoke Therapeutics Inc. (NASDAQ: STOK) Near the Top of Equities by Percentage Gain on 3/26

March 26, 2024

Via Investor Brand Network

Nasdaq Gains Over 50 Points; US Durable Goods Orders Rise In February ↗

March 26, 2024

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining over 50 points on Tuesday. The Dow traded up 0.08% to 39,346.40 while the NASDAQ rose 0.39% to 16,448.92. The S&P 500 also...

Via Benzinga

Topics Stocks

Stoke Therapeutics' Anti-Epilepsy Drug Candidate Shows Substantial, Sustained Reductions In Seizure Frequency In Pretreated Patients ↗

March 26, 2024

New data from Stoke Therapeutics' STK-001 studies reveal significant reductions in seizures and cognitive improvements in children with Dravet syndrome. STK-001 demonstrates promise as a well-tolerated...

Via Benzinga

Why Is NeuBase Therapeutics (NBSE) Stock Down 58% Today? ↗

March 26, 2024

NeuBase Therapeutics stock is down on Tuesday as NBSE investors react to details concerning an upcoming special shareholder meeting.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

March 26, 2024

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.